Reunert (RLO)
Johannesburg Exchange · South Africa · prices in ZAC · close of 22 Oct 2026
Key indicators
| Last close | ZAC 5,261.00 |
|---|---|
| 52-week range | 5,204.00 – 7,290.00 |
| Return, 1 month / 3 months | −9.6% / −8.9% |
| Return, 1 year / 3 years | −4.8% / −11.1% |
| Trend | Below its 200-day average |
| RSI (14) | 34 |
| Volatility (1 year) | 27.7% |
| Worst drawdown (1 year) | -26.5% |
| Average daily value traded | 2,218.86M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Reunert is a South African industrial group based in Johannesburg. It operates through businesses in electrical engineering, information and communication technology, and applied electronics. Its operations make and supply cables, electrical equipment and related products, and provide technology and communications solutions to customers in industry, commerce and the public sector. The group serves markets in South Africa and other parts of the continent, drawing on a long history in manufacturing and technology supply.
On this site Reunert appears as a stock on the Johannesburg Exchange (South Africa), code RLO, with prices in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Reunert (RLO) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 5,261.00 on 22 October 2026.
Its price-based Market X-Ray is 41 out of 100 (a weak price profile), ranking 161 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 4.8% and over the last three months it fell 8.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 23 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -14.1% | ||
| From 52-week high | -26.3% | ||
| Momentum | 27 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.9% | ||
| 6-month return | -23.5% | ||
| 12-month return, skipping the last month | 5.2% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.5% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 2,218.86M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −2.5% |
|---|---|
| 1 month | −9.6% |
| 3 months | −8.9% |
| 6 months | −23.5% |
| 1 year | −4.8% |
| 3 years | −11.1% |
| 5 years | +8.0% |
Signals
| 50-day / 200-day average | 5,569.72 / 6,124.76 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 117.11 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Jun 2023 | ZAC 0.8300 |
| 18 Jan 2023 | ZAC 2.2400 |
| 22 Jun 2022 | ZAC 0.7500 |
| 19 Jan 2022 | ZAC 2.0700 |
| 23 Jun 2021 | ZAC 0.7000 |
| 20 Jan 2021 | ZAC 1.9200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.